SR
Salveen Richter Roth Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Ionis Pharmaceuticals
IONS
$10.1B
| $63.07 | $45 |
29%
downside
| Sell |
3 Sep ‘25
7 days ago |
|
2
4D Molecular Therapeutics
FDMT
$323M
| $6.91 | $38 |
450%
upside
| Buy |
12 Aug ‘25
29 days ago |
|
3
Sarepta Therapeutics
SRPT
$1.84B
| $17.54 | $19 |
8%
upside
| Neutral |
7 Aug ‘25
1 month ago |
|
4
Acadia Pharmaceuticals
ACAD
$4.11B
| $24.39 | $17 |
30%
downside
| Sell |
7 Aug ‘25
1 month ago |
|
5
Enliven Therapeutics
ELVN
$1.19B
| $20.08 | $37 |
84%
upside
| Buy |
16 Jun ‘25
2 months ago |
|
|
6
4D Molecular Therapeutics
FDMT
$323M
| $6.91 | $44 |
537%
upside
| Buy |
9 May ‘25
4 months ago |
|
7
CRISPR Therapeutics
CRSP
$4.83B
| $53.09 | $47 |
11%
downside
| Neutral |
8 May ‘25
4 months ago |
|
8
Arcus Biosciences
RCUS
$1.2B
| $11.24 | $13 |
16%
upside
| Neutral |
8 May ‘25
4 months ago |
|
9
BioMarin Pharmaceuticals
BMRN
$10.5B
| $54.72 | $104 |
90%
upside
| Buy |
5 May ‘25
4 months ago |
|
10
Summit Therapeutics
SMMT
$13.1B
| $17.66 | $41 |
132%
upside
| Buy |
2 May ‘25
4 months ago |
|
11
Amicus Therapeutics
FOLD
$2.42B
| $7.84 | $9 |
15%
upside
| Neutral |
2 May ‘25
4 months ago |
|
12
Adaptive Biotechnologies
ADPT
$1.92B
| $12.61 | $10 |
21%
downside
| Buy |
2 May ‘25
4 months ago |
|
13
Regeneron Pharmaceuticals
REGN
$58.9B
| $556.10 | $804 |
45%
upside
| Buy |
30 Apr ‘25
4 months ago |
|
14
Biogen
BIIB
$20.5B
| $140.04 | $197 |
41%
upside
| Buy |
23 Apr ‘25
4 months ago |
|
15
Apellis Pharmaceuticals
APLS
$3.35B
| $26.51 | $32 |
21%
upside
| Neutral |
3 Mar ‘25
6 months ago |
|
16
Relay Therapeutics
RLAY
$683M
| $3.96 | $18 |
355%
upside
| Buy |
27 Feb ‘25
6 months ago |
|
17
Gilead Sciences
GILD
$142B
| $114.76 | $96 |
16%
downside
| Neutral |
12 Feb ‘25
7 months ago |
|
18
Moderna
MRNA
$9.63B
| $24.75 | $51 |
106%
upside
| Neutral |
29 Jan ‘25
7 months ago |
|
19
Denali Therapeutics
DNLI
$2.2B
| $15.05 | $40 |
166%
upside
| Buy |
28 Jan ‘25
7 months ago |
|
20
Intellia Therapeutics
NTLA
$1.27B
| $11.83 | $12 |
1%
upside
| Neutral |
14 Jan ‘25
7 months ago |
|
21
uniQure
QURE
$952M
| $17.36 | $20 |
15%
upside
| Neutral |
12 Dec ‘24
9 months ago |
|
22
Incyte
INCY
$16.6B
| $85.16 | $70 |
18%
downside
| Neutral |
30 Oct ‘24
10 months ago |
|
23
Alnylam Pharmaceuticals
ALNY
$61B
| $465.65 | $370 |
21%
downside
| Buy |
16 Aug ‘24
1 year ago |
|
24
Ultragenyx Pharmaceutical
RARE
$3.02B
| $31.32 | $76 |
143%
upside
| Buy |
2 Aug ‘24
1 year ago |
|
25
Agios Pharmaceuticals
AGIO
$2.05B
| $35.33 | $53 |
50%
upside
| Neutral |
4 Jun ‘24
1 year ago |
|